Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2025-12-25 @ 4:54 AM
NCT ID:
NCT00000818
Eligibility Criteria:
Inclusion Criteria
Concurrent Medication:
Allowed:
* Prophylaxis against AIDS-related opportunistic infections.
* Supportive therapies, such as medications for nausea, vomiting, anemia, and analgesia.
Patients must have:
* HIV infection.
* CD4 count 100 - 500 cells/mm3.
* At least two palpable lymph nodes.
* Plasma viremia.
* No CURRENT AIDS-defining conditions.
* No prior antiretroviral treatment.
Exclusion Criteria
Concurrent Medication:
Excluded during the first 8 weeks of study:
* Other antiretroviral agents.
* Steroids.
* Interleukins.
* Interferons.
* Cytotoxic chemotherapy.
Prior Medication:
Excluded:
* Prior antiretroviral therapy.
* Prior cytotoxic chemotherapy.
* Acute therapy for an infection or another medical illness within 14 days prior to study entry.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00000818
Study Brief:
Protocol Section:
NCT00000818